Oncology

COL10A1 expression distinguishes a subset of cancer-associated fibroblasts present in the stroma of high-risk basal cell carcinoma

We identified COL10A1 as a marker of high-risk BCC subtypes, particularly in sclerosing/infiltrative and basosquamous subtypes. This could serve as a prognostic biomarker and a target for personalized treatment.